General discussion, page-1340

A sell down here IMO is not necessarily a bad thing, those too impatient to hold now whilst we wait the known upcoming news flow are also those that will dump and stall a big run. I for one prefer them off the books before the start the northward journey.

For anyone who has researched the company and invested as such the fundamentals for that investment decision hasn't changed, I actually think it has strengthened. Particularly with the OSA trial, the board has managed to pivot and adapt these trials to give the best posible chance at success. Being adaptable to change is so important and in the current market now more so than ever.

It's incredibly difficult to judge market sentiment at the moment i've seen stocks climb rapidly on nothing but hopes and dreams and others that should run stay stagnant. I'm not sure how much the in vitro results will nudge the share price, particularly with oppies still in play. I think we will need to see positive results from the next phase of animal testing for ARDS, strong oppies conversion and OSA before we really get the re rate. The good news is we should see all that in the next 8 or so weeks.